Notice of Annual General Meeting in CellaVision AB (publ), April 27 2009

The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on Monday April 27 2009 at 16.00 at CellaVision AB, Scheelevägen 19 A, Delta 5, in Lund, Sweden.

About CellaVision
CellaVision AB develops, markets, and sells market leading image analysis based systems for routine analysis of blood and other body fluids. The company has a core competence in development of software and hardware for automatic image analysis of cells and cell changes for applications in health and medical care. The company develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials. The company’s associates have expertise in advanced imaging analysis, artificial intelligence, and automated microscopy.

The company headquarters are in Lund, Sweden. The company also has subsidiaries in Florida, USA, Toronto, Canada and Yokohama, Japan. For more information, visit www.cellavision.com.

CellaVision’s share is listed on First North Premier at the OMX Stockholm Stock Exchange. The company’s Certified Advisor is Remium AB.